4-((3-Allyl-4-(3,4-dichlorophenyl)thiazol-2(3H)-ylidene)amino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one hydrobromide

Catalog No. :
ACNVNV368
CAS No. :
479351-91-2
Molecular Formula :
C23H21BrCl2N4OS
Molecular Weight :
552.33

IUPAC Name:4-((3-allyl-4-(3,4-dichlorophenyl)thiazol-2(3H)-ylidene)amino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one hydrobromide

4-((3-Allyl-4-(3,4-dichlorophenyl)thiazol-2(3H)-ylidene)amino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one hydrobromide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((3-Allyl-4-(3,4-dichlorophenyl)thiazol-2(3H)-ylidene)amino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one hydrobromide
IUPAC Name4-((3-allyl-4-(3,4-dichlorophenyl)thiazol-2(3H)-ylidene)amino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one hydrobromide
Molecular FormulaC23H21BrCl2N4OS
Molecular Weight552.33
SMILESO=C1N(C2=CC=CC=C2)N(C)C(C)=C1N=C3SC=C(C4=CC=C(Cl)C(Cl)=C4)N3CC=C.[H]Br
InChI KeyORSGHNBBVOOJAP-UHFFFAOYSA-N
Synonym(Z)-4-((3-allyl-4-(3,4-dichlorophenyl)thiazol-2(3H)-ylidene)amino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one hydrobromide
CAS No.479351-91-2

Synthetic Route by SureRoute

1. ACNVNV368 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPCIR021 route compound structure diagram
    ACPCIR0215426-65-3 In Stock
  4. Then
  5. ACNVNV368 route product structure diagram
    ACNVNV368479351-91-2
Inquiry

2. ACNVNV368 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNVNV368 route product structure diagram
    ACNVNV368479351-91-2
Inquiry

Comments (0)